An epigenome-wide analysis of 887 individuals using advanced methylation screening technology identified 152 DNA methylation sites altered by smoking exposure. The study uncovered 61 previously unknown methylation changes, including a remarkable cluster of 12 sites within the ECEL1P1 gene region that persist decades after quitting smoking. These methylation patterns concentrate in hematopoietic stem and progenitor cells, suggesting these blood-forming cells harbor an epigenetic memory of tobacco exposure. This discovery illuminates how smoking's health consequences may endure long after cessation through persistent molecular programming of stem cells. The identification of smoking-induced changes in blood stem cell regulatory regions could explain why former smokers retain elevated risks for certain diseases years after quitting. While previous studies documented some smoking-related DNA methylation changes, this research reveals the extent and persistence of these molecular scars. The findings suggest that epigenetic modifications in stem cells may serve as biomarkers for assessing long-term smoking damage. However, as an unpeer-reviewed preprint, these results require validation through independent replication studies before clinical applications can be considered.